EGFR and lung carcinoma: Mutation detection of DNA extracted from CTC-enriched samples demonstrated activating mutations in the EGFR, KRAS, and AR genes in patients suffering from lung cancer, colorectal cancer (CRC), and castration-resistant prostate cancer (CRPC) respectively [65, 71, 72].